Assessment of the role of circulating breast cancer cells in tumor formation and metastatic potential using in vivo flow cytometry - PubMed (original) (raw)
Assessment of the role of circulating breast cancer cells in tumor formation and metastatic potential using in vivo flow cytometry
Derrick Hwu et al. J Biomed Opt. 2011 Apr.
Free article
Abstract
The identification of breast cancer patients who will ultimately progress to metastatic disease is of significant clinical importance. The quantification and assessment of circulating tumor cells (CTCs) has been proposed as one strategy to monitor treatment effectiveness and disease prognosis. However, CTCs have been an elusive population of cells to study because of their small number and difficulties associated with isolation protocols. In vivo flow cytometry (IVFC) can overcome these limitations and provide insights in the role these cells play during primary and metastatic tumor growth. In this study, we used two-color IVFC to examine, for up to ten weeks following orthotopic implantation, changes in the number of circulating human breast cells expressing GFP and a population of circulating hematopoietic cells with strong autofluorescence. We found that the number of detected CTCs in combination with the number of red autofluorescent cells (650 to 690 nm) during the first seven days following implantation was predictive in development of tumor formation and metastasis eight weeks later. These results suggest that the combined detection of these two cell populations could offer a novel approach in the monitoring and prognosis of breast cancer progression, which in turn could aid significantly in their effective treatment.
Similar articles
- A Noninvasive and Real-Time Method for Circulating Tumor Cell Detection by In Vivo Flow Cytometry.
Wei X, Zhou J, Zhu X, Yang X, Yang P, Wang Q. Wei X, et al. Methods Mol Biol. 2017;1634:247-262. doi: 10.1007/978-1-4939-7144-2_21. Methods Mol Biol. 2017. PMID: 28819857 - Real-time monitoring of rare circulating hepatocellular carcinoma cells in an orthotopic model by in vivo flow cytometry assesses resection on metastasis.
Fan ZC, Yan J, Liu GD, Tan XY, Weng XF, Wu WZ, Zhou J, Wei XB. Fan ZC, et al. Cancer Res. 2012 May 15;72(10):2683-91. doi: 10.1158/0008-5472.CAN-11-3733. Epub 2012 Mar 26. Cancer Res. 2012. PMID: 22454286 - A rapid and quantitative method to detect human circulating tumor cells in a preclinical animal model.
Tu SH, Hsieh YC, Huang LC, Lin CY, Hsu KW, Hsieh WS, Chi WM, Lee CH. Tu SH, et al. BMC Cancer. 2017 Jun 23;17(1):440. doi: 10.1186/s12885-017-3419-x. BMC Cancer. 2017. PMID: 28645267 Free PMC article. - Advances of In Vivo Flow Cytometry on Cancer Studies.
Suo Y, Gu Z, Wei X. Suo Y, et al. Cytometry A. 2020 Jan;97(1):15-23. doi: 10.1002/cyto.a.23851. Epub 2019 Jul 5. Cytometry A. 2020. PMID: 31273910 Review. - Circulating tumor cells in breast cancer--current status and perspectives.
Banys-Paluchowski M, Krawczyk N, Meier-Stiegen F, Fehm T. Banys-Paluchowski M, et al. Crit Rev Oncol Hematol. 2016 Jan;97:22-9. doi: 10.1016/j.critrevonc.2015.10.010. Epub 2015 Oct 31. Crit Rev Oncol Hematol. 2016. PMID: 26563820 Review.
Cited by
- Deep learning-enabled detection of rare circulating tumor cell clusters in whole blood using label-free, flow cytometry.
Vora N, Shekar P, Hanulia T, Esmail M, Patra A, Georgakoudi I. Vora N, et al. Lab Chip. 2024 Apr 16;24(8):2237-2252. doi: 10.1039/d3lc00694h. Lab Chip. 2024. PMID: 38456773 Free PMC article. - Label-free flow cytometry of rare circulating tumor cell clusters in whole blood.
Vora N, Shekhar P, Esmail M, Patra A, Georgakoudi I. Vora N, et al. Sci Rep. 2022 Jun 24;12(1):10721. doi: 10.1038/s41598-022-14003-5. Sci Rep. 2022. PMID: 35750889 Free PMC article. - In Vivo Flow Cytometry.
Zhu X, Liu Q, Fu Y, Zhang F, Gu Z, Gu B, Wei X. Zhu X, et al. Adv Exp Med Biol. 2021;3233:289-305. doi: 10.1007/978-981-15-7627-0_13. Adv Exp Med Biol. 2021. PMID: 34053032 - Heterogeneity of circulating tumor cell dissemination and lung metastases in a subcutaneous Lewis lung carcinoma model.
Fitzgerald JE, Byrd BK, Patil RA, Strawbridge RR, Davis SC, Bellini C, Niedre M. Fitzgerald JE, et al. Biomed Opt Express. 2020 Jun 8;11(7):3633-3647. doi: 10.1364/BOE.395289. eCollection 2020 Jul 1. Biomed Opt Express. 2020. PMID: 33014556 Free PMC article. - Prospects for the Use of Upconverting Nanoparticles as a Contrast Agent for Enumeration of Circulating Cells in vivo.
Bartosik PB, Fitzgerald JE, El Khatib M, Yaseen MA, Vinogradov SA, Niedre M. Bartosik PB, et al. Int J Nanomedicine. 2020 Mar 11;15:1709-1719. doi: 10.2147/IJN.S243157. eCollection 2020. Int J Nanomedicine. 2020. PMID: 32210561 Free PMC article.
Publication types
MeSH terms
LinkOut - more resources
Full Text Sources
Other Literature Sources
Medical